Mark Van Oene Pacific Biosciences Of California, Inc. (PACB) insider trading activity

Mark Van Oene is Officer of PACIFIC BIOSCIENCES OF CALIFORNIA, INC.. Currently has a direct ownership of 1.95 Million shares of PACB, which is worth approximately $2.22 Million. The most recent transaction as insider was on Mar 19, 2025, when has been sold 449,176 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.95M

19.38% 3M change

16.66% 12M change

Total Value Held $2.22 Million

Mark Van Oene Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 19 2025	BUY Grant, award, or other acquisition	-	449,176 Added 18.75%	1,946,871 Common Stock
Mar 03 2025	SELL Open market or private sale	$9,145 $1.41 p/Share	6,486 Reduced 0.43%	1,497,695 Common Stock
Feb 18 2025	SELL Open market or private sale	$189,453 $1.88 p/Share	100,773 Reduced 6.31%	1,496,681 Common Stock
Jan 10 2025	SELL Open market or private sale	$69,842 $2.03 p/Share	34,405 Reduced 2.11%	1,597,454 Common Stock
Aug 16 2024	SELL Open market or private sale	$63,098 $1.66 p/Share	38,011 Reduced 2.28%	1,630,815 Common Stock
Mar 04 2024	SELL Open market or private sale	$44,735 $4.87 p/Share	9,186 Reduced 0.55%	1,668,826 Common Stock
Feb 22 2024	BUY Grant, award, or other acquisition	-	798,076 Added 32.27%	1,674,687 Common Stock
Feb 16 2024	SELL Open market or private sale	$200,017 $5.96 p/Share	33,560 Reduced 3.69%	876,611 Common Stock
Jan 09 2024	SELL Open market or private sale	$240,963 $7.77 p/Share	31,012 Reduced 3.3%	910,171 Common Stock
Aug 16 2023	SELL Open market or private sale	$287,122 $11.0 p/Share	26,102 Reduced 2.7%	939,769 Common Stock
Mar 03 2023	SELL Open market or private sale	$59,483 $9.49 p/Share	6,268 Reduced 0.64%	965,871 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	328,500 Added 25.26%	972,139 Common Stock
Jan 10 2023	SELL Open market or private sale	$254,660 $9.53 p/Share	26,722 Reduced 4.0%	640,808 Common Stock
Aug 25 2022	BUY Grant, award, or other acquisition	-	300,000 Added 31.01%	667,528 Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	72,500 Added 16.53%	366,020 Common Stock
Jan 11 2022	SELL Open market or private sale	$590,260 $14.23 p/Share	41,480 Reduced 12.38%	293,520 Common Stock
Jan 08 2021	BUY Grant, award, or other acquisition	-	335,000 Added 50.0%	335,000 Common Stock

Also insider at

ILMN

ILLUMINA, INC. Healthcare

SVP Chief Commercial Officer

MVO

Mark Van Oene

Officer

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PACB shares.

Notify only if

Value

Insider Trading

Get notified when an Pacific Biosciences Of California, Inc. insider buys or sells PACB shares.

Notify only if

Operation

Value

Type

News

Receive news related to PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Track Activities on PACB

Account